NM_021098.3:c.3970-5G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.3970-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,609,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000097 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 splice_region, intron

Scores

2
Splicing: ADA: 0.007016
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.397

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-1210578-G-A is Benign according to our data. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1210578-G-A is described in CliVar as Benign. Clinvar id is 460102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000342 (52/152254) while in subpopulation EAS AF = 0.00174 (9/5182). AF 95% confidence interval is 0.000906. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 52 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 33 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 33 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 33 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.3931-5G>A splice_region_variant, intron_variant Intron 19 of 34 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 33 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.3931-5G>A splice_region_variant, intron_variant Intron 19 of 33 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.3970-5G>A splice_region_variant, intron_variant Intron 19 of 33 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 36 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.4020-5G>A splice_region_variant, intron_variant Intron 19 of 33 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*1883-5G>A splice_region_variant, intron_variant Intron 19 of 34 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*3417-5G>A splice_region_variant, intron_variant Intron 18 of 33 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 36 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 35 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.3970-5G>A splice_region_variant, intron_variant Intron 19 of 34 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.000342
AC:
52
AN:
152136
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000253
AC:
62
AN:
244720
AF XY:
0.000299
show subpopulations
Gnomad AFR exome
AF:
0.000657
Gnomad AMR exome
AF:
0.0000872
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00268
Gnomad FIN exome
AF:
0.0000520
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000968
AC:
141
AN:
1457014
Hom.:
0
Cov.:
40
AF XY:
0.0000993
AC XY:
72
AN XY:
724898
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33474
American (AMR)
AF:
0.0000671
AC:
3
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00189
AC:
75
AN:
39694
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86252
European-Finnish (FIN)
AF:
0.0000204
AC:
1
AN:
48920
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111756
Other (OTH)
AF:
0.0000995
AC:
6
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000342
AC:
52
AN:
152254
Hom.:
0
Cov.:
33
AF XY:
0.000349
AC XY:
26
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.000891
AC:
37
AN:
41538
American (AMR)
AF:
0.000196
AC:
3
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000124
Hom.:
0
Bravo
AF:
0.000397
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 30, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
18
DANN
Benign
0.82
PhyloP100
0.40
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0070
dbscSNV1_RF
Benign
0.53
SpliceAI score (max)
0.88
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.88
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202115678; hg19: chr16-1260578; API